RDHL
RedHill Biopharma Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.72
+1.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.00x
- Price / sales
- 0.46x
- Price / cash flow
- -0.54x
Enterprise value
- Enterprise value
- $1.8M
- EV / sales
- 0.18x
- EV / EBITDA
- -0.22x
- EV / EBIT
- -0.17x
- Market cap
- $4.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025